Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$224K Buy
13,165
+369
+3% +$7.91K 0.13% 149
2025
Q4
$329K Buy
12,796
+5,371
+72% +$124K 0.22% 121
2025
Q3
$160K Buy
+7,425
New +$169K 0.11% 148
2025
Q1
Sell
-3,290
Closed -$56.8K 605
2024
Q4
$56.8K Buy
3,290
+3,183
+2,975% +$49.4K 0.04% 215
2024
Q3
$1.49K Hold
107
﹤0.01% 692
2024
Q2
$3.06K Hold
107
﹤0.01% 608
2024
Q1
$4.08K Sell
107
-79
-42% -$2.99K ﹤0.01% 598
2023
Q4
$6.92K Buy
+186
New +$6.25K 0.01% 498

Other funds holding PGNY

Caitlin John's PGNY Position: Q1 2026 in Review

Caitlin John increased its Progyny (PGNY) stake by 2.9% in Q1 2026, buying an estimated $7.91K and bringing the position to 13,165 shares worth $224K. The position accounts for 0.13% of the portfolio, ranked #149.

Caitlin John first reported a position in PGNY in Q4 2023 and has held it in 8 quarters since. The position peaked at $329K in Q4 2025. 291 funds tracked by Wall St. Rank hold PGNY as of Q1 2026.

  • Caitlin John held 13,165 shares of Progyny worth $224K as of Q1 2026.
  • Caitlin John bought 369 Progyny shares in Q1 2026, an estimated $7.91K.
  • Progyny made up 0.13% of Caitlin John's portfolio in Q1 2026, its #149 holding.
  • Caitlin John first reported a position in Progyny in Q4 2023 and has held it in 8 quarters since.
  • Caitlin John's Progyny position peaked at $329K in Q4 2025.
  • 291 funds tracked by Wall St. Rank held Progyny as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.